Literature DB >> 18057574

An ecological approach to facilitate successful employment outcomes among people with multiple chemical sensitivity.

Lynn Koch1, Phillip Rumrill, Mary Hennessey, Courtney Vierstra, Richard T Roessler.   

Abstract

Many adults with multiple chemical sensitivity (MCS) must prematurely exit the workforce because of the severity of their MCS symptoms, the resulting disability stigma, and their unmet needs for on-the-job accommodations. To help individuals with MCS continue working or re-enter employment, rehabilitation professionals must understand the barriers resulting in unemployment and implement interventions to reduce or remove those barriers. In this article, the Ecological Model of Career Development is presented as a scheme for identifying barriers and implementing rehabilitation interventions to improve the employment outcomes among people with MCS.

Entities:  

Mesh:

Year:  2007        PMID: 18057574

Source DB:  PubMed          Journal:  Work        ISSN: 1051-9815


  4 in total

1.  Phenotypes of individuals affected by airborne chemicals in the general population.

Authors:  Nikolaj Drimer Berg; Allan Linneberg; Asger Dirksen; Jesper Elberling
Journal:  Int Arch Occup Environ Health       Date:  2008-08-28       Impact factor: 3.015

2.  General practitioners' experiences with provision of healthcare to patients with self-reported multiple chemical sensitivity.

Authors:  Sine Skovbjerg; Jeanne Duus Johansen; Alice Rasmussen; Hanne Thorsen; Jesper Elberling
Journal:  Scand J Prim Health Care       Date:  2009       Impact factor: 2.581

3.  Unmet health care needs for persons with environmental sensitivity.

Authors:  Pamela Reed Gibson; Shannon Kovach; Alexis Lupfer
Journal:  J Multidiscip Healthc       Date:  2015-01-23

4.  Transcranial pulsed electromagnetic fields for multiple chemical sensitivity: study protocol for a randomized, double-blind, placebo-controlled trial.

Authors:  Marie Thi Dao Tran; Sine Skovbjerg; Lars Arendt-Nielsen; Karl Bang Christensen; Jesper Elberling
Journal:  Trials       Date:  2013-08-16       Impact factor: 2.279

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.